Companies
From start-ups to market leaders, access critical company intelligence on a global scale
Experience what our solutions have to offer with free access to highlights of our data, insights and analysis.
From start-ups to market leaders, access critical company intelligence on a global scale
From industry deep dives to global trends, access authoritative research from our experts
Uncover your next opportunity with trusted data & insights that cut across industries
Discover the disruptive forces shaping tomorrow's world, today
Explore our diverse collection of unique datasets and find the advantage you need
Get clarity into the latest emerging themes with our reports
Experience what our solutions have to offer with free access to highlights of our data, insights and analysis.
From start-ups to market leaders, access critical company intelligence on a global scale
From industry deep dives to global trends, access authoritative research from our experts
Uncover your next opportunity with trusted data & insights that cut across industries
Discover the disruptive forces shaping tomorrow's world, today
Explore our diverse collection of unique datasets and find the advantage you need
Get clarity into the latest emerging themes with our reports
ESG (Environmental, Social, and Governance) Report
Sustainability is an important theme for 2021 and beyond
The pharma industry is under increasing pressure to become more sustainable, with many companies responding by improving their impact on the environment and society. The industry has deeply rooted environmental, social, end governance issues requiring collaborative, proactive steps to achieve sustainability goals. The pharma industry’s contribution to environmental issues is multifaceted, and is linked to R&D, supply chain, transport logistics, disposal of pharmaceutical products, and chemistry.
Elements within the pharmaceutical industry that contribute to social sustainability include pricing, market access, quality of supply chains, R&D practices, and development of drugs to treat rare diseases.
Adopting a holistic approach that encompasses all environmental, social, and governance issues can help company leaders ensure that all aspects of sustainability are covered in their ESG strategy.